SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-222585
Filing Date
2019-08-15
Accepted
2019-08-15 17:14:33
Documents
8
Period of Report
2019-08-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d774095d8k.htm 8-K 28043
2 EX-1.1 d774095dex11.htm EX-1.1 191351
3 EX-5.1 d774095dex51.htm EX-5.1 5695
4 EX-99.1 d774095dex991.htm EX-99.1 12322
5 EX-99.2 d774095dex992.htm EX-99.2 12804
6 GRAPHIC g774095g10k35.gif GRAPHIC 3603
7 GRAPHIC g774095g35b39.gif GRAPHIC 3215
8 GRAPHIC g774095g65i43.gif GRAPHIC 1426
  Complete submission text file 0001193125-19-222585.txt   263211
Mailing Address 500 TOTTEN POND ROAD WALTHAM MA 02451
Business Address 500 TOTTEN POND ROAD WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 191031044
SIC: 2834 Pharmaceutical Preparations